MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,250,316 | +2510.3% | 172,900 | +4230.1% | 0.07% | +2366.7% |
| Q1 2023 | $967,344 | -34.9% | 3,993 | -82.5% | 0.00% | -50.0% |
| Q3 2022 | $1,487,000 | -38.1% | 22,876 | -24.0% | 0.01% | -45.5% |
| Q3 2021 | $2,402,000 | -54.4% | 30,100 | -61.9% | 0.01% | -74.4% |
| Q1 2020 | $5,267,000 | +100.1% | 78,900 | +158.5% | 0.04% | +168.8% |
| Q3 2019 | $2,632,000 | -56.6% | 30,521 | -47.3% | 0.02% | -50.0% |
| Q2 2019 | $6,068,000 | +133.3% | 57,900 | +178.8% | 0.03% | +166.7% |
| Q1 2019 | $2,601,000 | -56.5% | 20,767 | -60.8% | 0.01% | -58.6% |
| Q4 2018 | $5,974,000 | -70.6% | 53,000 | -44.1% | 0.03% | -65.5% |
| Q3 2018 | $20,300,000 | +335.6% | 94,800 | +137.6% | 0.08% | +342.1% |
| Q1 2018 | $4,660,000 | -57.7% | 39,900 | -66.8% | 0.02% | -60.4% |
| Q4 2017 | $11,015,000 | – | 120,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |